Company’s Retail Presence Grows to 57 Locations in Florida and 147 Nationwide
NEW YORK, Jan. 23, 2023 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, announces the opening of its Clermont dispensary, located at 1900 S. Highway 27, Clermont FL 34711. The new dispensary is Curaleaf’s 57th in the Sunshine State and 147th nationwide.
Conveniently located near Clermont’s top shopping, entertainment and dining options, the new 2,682 sq. ft. dispensary opened its doors to patients over the weekend. The facility will be open to service patients from 9:00 a.m. to 8:30 p.m. Monday through Saturday and 10:00 a.m. to 7:00 p.m. on Sunday. A grand opening celebration is planned for Friday, February 3, and will commence with a ribbon cutting at 10:00 a.m. followed by festivities throughout the day including swag giveaways, games, prizes and local vendors.
“We are thrilled to welcome Curaleaf Clermont to the South Lake Chamber,” said David Colby, President & CEO South Lake Chamber of Commerce. “With a patient-focused approach and a commitment to community, Curaleaf Clermont will be a valuable resource to residents of Lake County and Floridians visiting one of our many attractions in the area.”
“This new location is in the heart of one of Florida’s fastest-growing communities,” said Matt Darin, CEO of Curaleaf. “We continue to expand our retail footprint in the state, and our team is committed to providing our expanding patient community with a tailored, educational approach to cannabis and a seamless retail experience.”
The new dispensary will offer a wide variety of premium cannabis products, including high-quality flower and pre-rolls, BlueKudu Chocolate, Select Squeeze, Select X-Bites, Select Elite, Elite Live and Live Rosin vape cartridges, as well as other concentrates by Curaleaf. Patients can shop inside the new location with guidance from Curaleaf’s knowledgeable staff or pre-order online for in-store or curbside pickup.
For more information on Curaleaf’s locations, patient resources and products in Florida, please visit: https://curaleaf.com/dispensary/florida.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select and Grassroots, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 21 states with 147 dispensaries, 29 cultivation sites, and employs nearly 6,000 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “expects” or, “proposed”, “is expected”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the opening of Curaleaf Clermont. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s latest annual information form filed March 9, 2022, which is available under the Company’s SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications
SOURCE Curaleaf Holdings, Inc.